» Articles » PMID: 36124295

Skeletal Muscle Models for Type 2 Diabetes

Overview
Specialty Biophysics
Date 2022 Sep 20
PMID 36124295
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus, a metabolic disorder characterized by abnormally elevated blood sugar, poses a growing social, economic, and medical burden worldwide. The skeletal muscle is the largest metabolic organ responsible for glucose homeostasis in the body, and its inability to properly uptake sugar often precedes type 2 diabetes. Although exercise is known to have preventative and therapeutic effects on type 2 diabetes, the underlying mechanism of these beneficial effects is largely unknown. Animal studies have been conducted to better understand the pathophysiology of type 2 diabetes and the positive effects of exercise on type 2 diabetes. However, the complexity of systems and the inability of animal models to fully capture human type 2 diabetes genetics and pathophysiology are two major limitations in these animal studies. Fortunately, models capable of recapitulating human genetics and physiology provide promising avenues to overcome these obstacles. This review summarizes current type 2 diabetes models with focuses on the skeletal muscle, interorgan crosstalk, and exercise. We discuss diabetes, its pathophysiology, common type 2 diabetes skeletal muscle models, interorgan crosstalk type 2 diabetes models, exercise benefits on type 2 diabetes, and type 2 diabetes models with exercise.

Citing Articles

Effect of viral hepatitis on type 2 diabetes: A Mendelian randomization study.

Yu Y, Hu G, Tong K, Yang X, Wu J, Yu R World J Diabetes. 2024; 15(2):220-231.

PMID: 38464364 PMC: 10921171. DOI: 10.4239/wjd.v15.i2.220.


Diabetes diminishes muscle precursor cell-mediated microvascular angiogenesis.

Acosta F, Pacelli S, Rathbone C PLoS One. 2023; 18(8):e0289477.

PMID: 37540699 PMC: 10403078. DOI: 10.1371/journal.pone.0289477.


Insulin Resistance Model: A Recent Update.

Yudhani R, Sari Y, Nugrahaningsih D, Sholikhah E, Rochmanti M, Purba A J Obes. 2023; 2023:1964732.

PMID: 36714242 PMC: 9876677. DOI: 10.1155/2023/1964732.

References
1.
Gancheva S, Jelenik T, Alvarez-Hernandez E, Roden M . Interorgan Metabolic Crosstalk in Human Insulin Resistance. Physiol Rev. 2018; 98(3):1371-1415. DOI: 10.1152/physrev.00015.2017. View

2.
Aoi W, Tanimura Y . Roles of Skeletal Muscle-Derived Exosomes in Organ Metabolic and Immunological Communication. Front Endocrinol (Lausanne). 2021; 12:697204. PMC: 8476901. DOI: 10.3389/fendo.2021.697204. View

3.
Hilton T, Tuttle L, Bohnert K, Mueller M, Sinacore D . Excessive adipose tissue infiltration in skeletal muscle in individuals with obesity, diabetes mellitus, and peripheral neuropathy: association with performance and function. Phys Ther. 2008; 88(11):1336-44. PMC: 2579904. DOI: 10.2522/ptj.20080079. View

4.
Boucher J, Kleinridders A, Kahn C . Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014; 6(1). PMC: 3941218. DOI: 10.1101/cshperspect.a009191. View

5.
Gundelach L, Huser M, Beutner D, Ruther P, Bruegmann T . Towards the clinical translation of optogenetic skeletal muscle stimulation. Pflugers Arch. 2020; 472(5):527-545. PMC: 7239821. DOI: 10.1007/s00424-020-02387-0. View